Awad SM, Mohamed MS, Khodair MAEF, El-Hameed RHA. Synthesis and Evaluation of Cytotoxic Activity of Certain Benzo[h]chromene Derivatives.
Anticancer Agents Med Chem 2021;
21:963-986. [PMID:
32981512 DOI:
10.2174/1871520620666200925103742]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2020] [Revised: 07/21/2020] [Accepted: 08/08/2020] [Indexed: 11/22/2022]
Abstract
BACKGROUND
Benzo[h]chromenes attracted great attention because of their widespread biological activities, including anti-proliferate activity, and the discovery of novel effective anti-cancer agents is imperative.
OBJECTIVE
The main objective was to synthesize new benzo[h]chromene derivatives and some reported derivatives, and then test all of them for their anti-cancer activities.
METHODS
The structures of the newly synthesized derivatives were confirmed by elemental and spectral analysis (IR, Mass, 1H-NMR and 13C-NMR). 35 compounds were selected by the National Cancer Institute (NCI) for single-dose testing against 60 cell lines and 3 active compounds were selected for 5-doses testing. Also, these 3 compounds were tested as EGFR-inhibitors; using sorafenib as standard, and as Tubulin polymerization inhibitors using colchicines as a standard drug. Moreover, molecular docking study for the most active derivative on these 2 enzymes was also carried out.
RESULTS
Compounds 1a, 1c and 2b have the highest activities among all 35 tested compounds especially compound 1c.
CONCLUSION
compound 1c has promising anti-cancer activities compared to the used standards and may need further modification and investigations.
Collapse